Prevention of human papillomavirus-associated cancers

Seminars in Oncology

Volumn 42, Issue 2, 2015, Pages 272-283

  Dillner, Joakim ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CARCINOGENICITY; FOLLOW UP; GAMMAPAPILLOMAVIRUS; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SCREENING TEST; UTERINE CERVIX CANCER; WART VIRUS; COMPLICATION; NEOPLASMS; PAPILLOMAVIRUS INFECTION; VIROLOGY;

HUMANS; NEOPLASMS; PAPILLOMAVIRUS INFECTIONS;

EID: 84926284449     PISSN: 00937754     EISSN: 15328708     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2014.12.028     Document Type: Review

References (46)

1. H.U. Bernard, R.D. Burk, Z. Chen, K. van Doorslaer, H. Hausen, and E.M. de Villiers Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments Virology 401 2010 70 79
2. D. Bottalico, Z. Chen, and A. Dunne The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera J Infect Dis 204 2011 787 792
3. Z. Chen, M. Schiffman, R. Herrero, and R.D. Burk Identification and characterization of two novel human papillomaviruses (HPVs) by overlapping PCR: HPV102 and HPV106 J Gen Virol 88 2007 2952 2955
4. D. Chouhy, M. Gorosito, and A. Sanchez New generic primer system targeting mucosal/genital and cutaneous human papillomaviruses leads to the characterization of HPV 115, a novel Beta-papillomavirus species 3 Virology 397 2010 205 216
5. J. Ekstrom, D. Bzhalava, D. Svenback, O. Forslund, and J. Dillner High throughput sequencing reveals diversity of human papillomaviruses in cutaneous lesions Int J Cancer 129 2011 2643 2650
6. J. Ekstrom, O. Forslund, and J. Dillner Three novel papillomaviruses (HPV109, HPV112 and HPV114) and their presence in cutaneous and mucosal samples Virology 397 2010 331 336
7. V. Foulongne, V. Sauvage, and C. Hebert Human skin microbiota: high diversity of DNA viruses identified on the human skin by high throughput sequencing PLoS One 7 2012 e38499
8. A. Kohler, M. Gottschling, and K. Manning Genomic characterization of ten novel cutaneous human papillomaviruses from keratotic lesions of immunosuppressed patients J Gen Virol 92 2011 1585 1594
9. J. Li, H. Cai, and Z. Xu Nine complete genome sequences of cutaneous human papillomavirus genotypes isolated from healthy skin of individuals living in rural He Nan province, China J Virol 86 2012 11936
10. R.J. Nobre, E. Herraez-Hernandez, and J.W. Fei E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures J Virol 83 2009 2907 2916
11. N. Vasiljevic, K. Hazard, J. Dillner, and O. Forslund Four novel human betapapillomaviruses of species 2 preferentially found in actinic keratosis J Gen Virol 89 2008 2467 2474
12. N. Vasiljevic, K. Hazard, and L. Eliasson Characterization of two novel cutaneous human papillomaviruses, HPV93 and HPV96 J Gen Virol 88 2007 1479 1483
13. E.M. de Villiers, C. Fauquet, T.R. Broker, H.U. Bernard, and H. zur Hausen Classification of papillomaviruses Virology 324 2004 17 27
14. S. Duensing, and K. Munger Mechanisms of genomic instability in human cancer: insights from studies with human papillomavirus oncoproteins Int J Cancer 109 2004 157 162
15. M. Schiffman, G. Clifford, and F.M. Buonaguro Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline Infect Agent Cancer 4 2009 8
16. IARC Monographs on the evaluation of carcinogenic risks to humans volume 100b: a review of human carcinogens: biological agents 2012 International Agency for Research on Cancer Lyon
17. D. Bzhalava, P. Guan, S. Franceschi, J. Dillner, and G. Clifford A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types Virology 445 1-2 2013 224 231
18. P. Guan, G.M. Clifford, and S. Franceschi Human papillomavirus types in glandular lesions of the cervix: a meta-analysis of published studies Int J Cancer 132 2013 248 250
19. P. Guan, R. Howell-Jones, and N. Li Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer Int J Cancer 131 2012 2349 2359
20. D. Forman, C. de Martel, and C.J. Lacey Global burden of human papillomavirus and related diseases Vaccine 30 Suppl 5 2012 F12 F23
21. F. Bray, R. Sankila, J. Ferlay, and D.M. Parkin Estimates of cancer incidence and mortality in Europe in 1995 Eur J Cancer 38 1 2002 99 166
22. K. Nanda, D.C. McCrory, and E.R. Myers Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review Ann Intern Med 132 10 2000 810 819
23. M.H. Mayrand, E. Duarte-Franco, and I. Rodrigues Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer N Engl J Med 357 16 2007 1579 1588
24. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1 1999 12 19
25. L. Kotaniemi-Talonen, P. Nieminen, A. Anttila, and M. Hakama Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting Br J Cancer 93 8 2005 862 867
26. N.W. Bulkmans, L. Rozendaal, and P.J. Snijders POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women Int J Cancer 110 1 2004 94 101
27. P. Naucler, W. Ryd, and S. Törnberg Human papillomavirus and Papanicolaou tests to screen for cervical cancer N Engl J Med 357 16 2007 1589 1597
28. G. Ronco, P. Giorgi-Rossi, and F. Carozzi Human papillomavirus testing and liquid-based cytology in primary screening of women younger than 35 years: results at recruitment for a randomised controlled trial Lancet Oncol 7 7 2006 547 555
29. G. Ronco, J. Dillner, and K.M. Elfström Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet 383 9916 2014 524 532
30. M. Lehtinen, and J. Dillner Clinical trials of human papillomavirus vaccines and beyond Nat Rev Clin Oncol 10 2013 400 410
31. P. Naucler, W. Ryd, and S. Törnberg HPV type-specific risks of high-grade CIN during 4 years of follow-up: a population-based prospective study Br J Cancer 97 1 2007 129 132
32. K.M. Elfstrom, V. Smelov, and A.L. Johansson Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial BMJ 348 2014 130
33. K.M. Elfström, V. Smelov, and A.L. Johansson Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial Int J Cancer 136 2 2015 350 359
34. V. Smelov, K.M. Elfström, and A.L.V. Johansson Long-term HPV type-specific risks for high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial Int J Cancer 136 5 2015 1171 1180
35. J. Dillner, M. Rebolj, and P. Birembaut Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study BMJ 337 2008 Oct 13 a1754
36. H.A. Katki, W.K. Kinney, and B. Fetterman Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice Lancet Oncol 12 7 2011 663 672
37. I.M. de Kok, J. van Rosmalen, and J. Dillner Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model Br Med J 344 2012 e670
38. J. Dillner Primary human papillomavirus testing in organized cervical screening Curr Opin Obstet Gynecol 25 2013 11 16
39. M. Poljak, J. Cuzick, B.J. Kocjan, T. Iftner, J. Dillner, and M. Arbyn Nucleic acid tests for the detection of alpha human Papillomaviruses Vaccine S5 2012 F100 F106
40. C. Eklund, T. Zhou, and J.WHO Dillner Human Papillomavirus Laboratory Network. Global proficiency study of human papillomavirus genotyping J Clin Microbiol 48 11 2010 4147 4155
41. C. Eklund, O. Forslund, K.L. Wallin, T. Zhou, and J. Dillner WHO Human Papillomavirus Laboratory Network. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology J Clin Microbiol 50 7 2012 2289 2298
42. C. Eklund, O. Forslund, K.L. Wallin, and J. Dillner Global improvement in genotyping of human papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study J Clin Microbiol 52 2014 449 459
43. M. Hakama, N. Malila, and J. Dillner Randomised healthservice studies Int J Cancer 131 2012 2898 2902
44. C. de Martel, J. Ferlay, and S. Franceschi Global burden of cancers attributable to infections in 2008: a review and synthetic analysis Lancet Oncol 13 6 2012 607 615
45. I. Baussano, J. Dillner, F. Lazzarato, G. Ronco, and S. Franceschi Upscaling human papillomavirus vaccination in high-income countries: impact assessment based on transmission model Infect Agents Cancer 9 1 2014 4
46. C.P. Wild, J. McLaughlin, and J. Bucher Translational cancer research: balancing prevention and treatment to combat cancer globally J Natl Cancer Inst 107 1 2015 dju353